This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
04/29/16 - 2:39:06 PM ET (BATS BZX Real-time Price)
Div Yield: --
SRPT Day's Range
SRPT 52 Week Range
SRPT Business Summary
Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases.View SRPT
Sarepta Therapeutics Inc - SRPT - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Sarepta Therapeutics Inc as a
Sell with a ratings score of D-.
Report Snippet: We rate SAREPTA THERAPEUTICS INC (SRPT) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.